Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19621509 | 1.00 | TSHR (0.38) | TSHRMAPK1CRBN | |
| SCHEMBL3707344 | 0.76 | TSHR (0.36) | TSHRMAPK1 | |
| SCHEMBL19621415 | 0.76 | TSHR (0.36) | TSHRMAPK1 | |
| SCHEMBL12812311 | 0.76 | TSHR (0.36) | TSHRMAPK1 | |
| SCHEMBL13255134 | 0.76 | TSHR (0.41) | TSHRMAPK1 | |
| SCHEMBL14186834 | 0.72 | TSHR (0.34) | TSHRMAPK1 | |
| SCHEMBL14174371 | 0.67 | CYP19A1 (0.33) | TSHRMAPK1 | |
| SCHEMBL5051698 | 0.67 | CYP19A1 (0.33) | TSHRMAPK1 | |
| SCHEMBL7895665 | 0.67 | TP53 (0.33) | TSHRMAPK1 | |
| SCHEMBL6861301 | 0.67 | OPRK1 (0.38) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12458918-B2 | Process and apparatus for treating methane-containing gas | KANADEVIA INOVA AG (CH) | 2025-11-04 | — | — | US | disclosed |
| US-20250262588-A1 | PROCESS AND APPARATUS FOR TREATING METHANE-CONTAINING GAS | KANADEVIA INOVA AG (CH) | 2025-08-21 | — | — | US | disclosed |
| EP-4536380-A1 | PROCESS AND APPARATUS FOR TREATING METHANE-CONTAINING GAS | Kanadevia Inova AG (CH) | 2025-04-16 | — | — | EP | disclosed |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | ALKALAY RACHEL (IL) | 2024-11-28 | — | — | US | disclosed |
| US-20240226218-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | Novel Concepts Medical Ltd (IL) | 2024-07-11 | — | — | US | disclosed |
| WO-2023237568-A1 | PROCESS AND APPARATUS FOR TREATING METHANE-CONTAINING GAS | HITACHI ZOSEN INOVA AG (CH) | 2023-12-14 | — | — | WO | disclosed |
| EP-4289498-A1 | METHOD AND DEVICE FOR THE TREATMENT OF GAS CONTAINING METHANE | Hitachi Zosen Inova AG (CH) | 2023-12-13 | — | — | EP | disclosed |
| US-20230346866-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NON-MALIGNANT RESPIRATORY DISEASE | Novel Concepts Medical Ltd (IL) | 2023-11-02 | — | — | US | disclosed |
| US-20230181665-A1 | TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND THYROID DISEASES | Novel Concepts Medical Ltd (IL) | 2023-06-15 | — | — | US | disclosed |
| US-20230134432-A1 | COMPOSITIONS AND METHODS FOR TREATING SOLID AND SOFT TUMORS AND PROLIFERATIVE DISEASES | Novel Concepts Medical Ltd (IL) | 2023-05-04 | — | — | US | disclosed |
| US-20080193874-A1 | Having acrylic ester functionality with acid labile ester ring functionality and sulfonium sulfonate acid salt; high resolution semiconductor microfabrication patterns; excimer laser lithography | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-08-14 | — | — | US | disclosed |
| US-20080176168-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-07-24 | — | — | US | disclosed |
| US-20080166660-A1 | Having acrylic ester functionality with acid labile ester ring functionality and sulfonium sulfonate acid salt; high resolution semiconductor microfabrication patterns; excimer laser lithography | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-07-10 | — | — | US | disclosed |
| US-20080081293-A1 | Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1873143-A1 | A salt suitable for an acid generator and a chemically amplified resist composition containing the same | Sumitomo Chemical Company, Limited (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-20070218401-A1 | liquid immersion lithography, solves problem of defect caused by residual fluid droplets on the resist film; blend of resin containing no fluorine and acid labile group, and an acrylic fluoro-copolymer with units of a fluoromonomer and units of acid labile, lactone, or hydroxy-functional group | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070027336-A1 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20050181080-A1 | Chinese traditional medicines for psoriasis | HUANG HSU-SHAN (TW) | 2005-08-18 | — | — | US | disclosed |
| US-20030165533-A1 | Chinese traditional medicines for psoriasis | HUANG HSU-SHAN (TW) | 2003-09-04 | — | — | US | disclosed |
| US-20030152588-A1 | Chinese traditional medicines for psoriasis | HUANG HSU-SHAN (TW) | 2003-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027336-A1 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SLC26A3, NHERF1, HCN4 | TSHR 2167/4885MAPK1 1937/4885CRBN 1594/4885 |
| US-20080081293-A1 | Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same | HCN3, HCN1, NHERF1 | TSHR 618/4885MAPK1 1437/4885CRBN 1935/4885 |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | TPO, TNF, ADAMTS13 | TSHR 12/4885MAPK1 1771/4885CRBN 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.